Post Pandemic Pneumococcal Carriage Among Children and Adults

Description

The PI propose to conduct a genomic epidemiology study of pneumococcal carriage among children and adults in a large metropolitan city. These data will allow PI to assess the post-pandemic population structure, investigate the phylogenetic relationship between isolates from children and adults, and compare pneumococcal populations across diverse geographic areas.

Conditions

Pneumococcal Carriage

Talk to us

Study Overview

On this page

Study Details

Study overview

The PI propose to conduct a genomic epidemiology study of pneumococcal carriage among children and adults in a large metropolitan city. These data will allow PI to assess the post-pandemic population structure, investigate the phylogenetic relationship between isolates from children and adults, and compare pneumococcal populations across diverse geographic areas.

Post-Pandemic Genomic Epidemiology of Pneumococcal Carriage Among Children and Adults in the General US Population

Post Pandemic Pneumococcal Carriage Among Children and Adults

Condition
Pneumococcal Carriage
Intervention / Treatment

-

Contacts and Locations

Orlando

University of Central Florida, Orlando, Florida, United States, 32827

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Children, ages 7 to 59 months (less than 5 years)
  • * Adults, ages 50 and older
  • * Ability to provide informed consent (from parents for children participants)
  • * ability to read and speak in English
  • * Agree to comply with study procedures (complete online data questionnaire and provide a nasopharyngeal collection).
  • * Have been on an antibiotic in the last 2 weeks
  • * Have a respiratory infection that would make an nasopharyngeal collection improbable
  • * Have underlying developmental or chronic conditions impacting immune or respiratory function (e.g., immunocompromised, cystic fibrosis, cerebral palsy, paralysis)
  • * Adults unable to consent, individuals who are not yet adults, and prisoners will be excluded from this study.

Ages Eligible for Study

7 Months to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

Yes

Collaborators and Investigators

University of Central Florida,

Taj Azarian, PhD, PRINCIPAL_INVESTIGATOR, University of Central Florida

Study Record Dates

2026-03